USA flag logo/image

An Official Website of the United States Government

A New Web 2.0 Platform for Analyzing Genomics Data with Application to the Study

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
93529
Program Year/Program:
2009 / STTR
Agency Tracking Number:
CA139639
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
MYATT AND JOHNSON, INC.
415 E. Pine St. Apt. 614 Orlando, FL -
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2009
Title: A New Web 2.0 Platform for Analyzing Genomics Data with Application to the Study
Agency: HHS
Contract: 1R41CA139639-01A1
Award Amount: $168,346.00
 

Abstract:

DESCRIPTION (provided by applicant): A major research focus for gaining insight into the molecular basis for cancer, with the goal of identifying new treatments, is the systematic profiling of cancer cells. This includes the generation of compound potency data and gene/protein expression data. This has led to the generation of massive amounts of disparate data that must be associated in context sensitive ways and collectively data mined in order to reach the goal of finding new treatments. The aim of this p roject is to develop a new computing platform that will enable researchers throughout the world to interactively collaborate on the analysis of this valuable information. A new web-based platform will be developed that, incorporates recent and emerging Web 2.0 and Enterprise software standards and technologies. This platform will incorporate public cancer cell-based data, including genomics, proteomics, and cytotoxic potency data. It will make possible the systematic exploration of the data through interact ive data analysis and visualization tools in order to generate hypotheses. The proposed project will include the development of new statistical methods to identify groups of cells over which selected genes and compounds are highly and significantly correla ted. The platform will be used to identify candidate target genes and drugs for cancer chemotherapy, and to determine factors that contribute to chemoresistance and sensitivity. PUBLIC HEALTH RELEVANCE: Cancer is a major cause of mortality throughout t he world. Many types of cancers lack effective treatments, and new treatment approaches have the potential to positively impact large patient populations. This project will build a new data analysis and visualization platform to aid in identifying biomarke rs predictive of drug efficacy for optimizing cancer chemotherapy.

Principal Investigator:

Glenn J. Myatt
GMYATT@LEADSCOPE.COM

Business Contact:

Glenn J. Myatt
Small Business Information at Submission:

MYATT AND JOHNSON, INC.
MYATT AND JOHNSON, INC. 241 WARD RIDGE RD JASPER, GA 30143

EIN/Tax ID: 120882455
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Research Institution Information:
OHIO STATE UNIVERSITY
Office of Sponsored Programs
1960 Kenny Road
COLUMBUS, OH 43210 6203
RI Type: Nonprofit college or university